Consumer Cyclical
Royal Orchid Hotels Limited Rohltd Introduces Regenta Place Brand to Cyberabad
Royal Orchid Hotels Limited ROHLTD launches Regenta Place Hi-Tech City in Cyberabad, offering a blend of contemporary hospitality and convenience.
Royal Orchid Hotels Ltd. (ROHL) announces the launch of Regenta Place Hi-Tech City, Hyderabad, marking the Regenta Place brand’s debut in Cyberabad. The property introduces a perfect blend of convenient location, comfortable stay with contemporary hospitality. Nestled in the heart of HITEC City, Hyderabad’s premier information technology and business district, the property brings together old-world charm and contemporary hospitality.
Strategic Location
Regenta Place Hi-Tech City, Hyderabad, is designed to offer a convenient stay for both business and leisure travelers. The Mindspace IT Hub, Hitech City, is just a five-minute walk from the property, making it an ideal choice for corporate guests. IKEA, Inorbit Mall, and Shilparamam Handicraft Expo are just two kms away, making it the perfect choice for those looking to combine their stay with shopping.
Amenities and Facilities
The hotel also offers easy accessibility as it is 30 kms from the Rajiv Gandhi International Airport, while the Raidurg Metro Station is a short two-minute walk, and Charminar, the heart of the old city, is 20 minutes away. The new property features 74 thoughtfully designed keys, including 2 Suites, 6 Executive Rooms, and 66 Business Rooms, offering a balanced blend of functionality and comfort. Guests can enjoy a range of amenities, including Good Vibes Only – a multi-cuisine café, and a versatile rooftop banquet space.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Royal Orchid Hotels Limited
Royal Orchid Hotels Limited belongs to the Consumer Cyclical › Lodging sector. Here’s a quick read on where the business and the stock stand today.
Royal falls 9.9% over three months and has not found a floor yet. The business compounds revenue at 32.1% and profits at 17.2% CAGR. That is strong double-digit growth on both counts. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The stock sits at 18% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 32.1% and profits at 17.2% CAGR, with D/E of 0.00. Meanwhile, the stock dips 9.9% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Royal Orchid Hotels Limited.
Consumer Cyclical
Le Travenues Technology Limited (ixigo) Delivers All-time High PAT of Rs.63.42 Cr in Q2 FY27
Le Travenues Technology Limited (IXIGO) reports all-time high PAT of Rs.63.42 Cr in Q2 FY27, with Hotels emerging as a significant growth driver.
Le Travenues Technology Limited (NSE: IXIGO) announced its standalone and consolidated financial results for the quarter ended September 30, 2026. The company delivered resilient growth in Q2 FY27, supported by its diversified multimodal travel business. The Gross Transaction Value (GTV) grew 22% YoY to Rs. 5,304.47 Cr, while Revenue from Operations increased 13% YoY to Rs. 320.96 Cr. Notably, the Profit After Tax (PAT) reached an all-time high of Rs. 63.42 Cr, aided by the partial sale of a stake in Freshbus.
Key Financial Highlights
The company’s Contribution Margin rose 14% YoY to Rs. 124.86 Cr. Additionally, the Adjusted EBITDA stood at Rs. 23.58 Cr in Q2 FY27, down 17% YoY from Rs. 28.48 Cr in Q2 FY26. The revenue from operations grew 13% YoY to Rs. 320.96 Cr.
Growth in Hotels Business
The Hotels business emerged as ixigo’s fastest-growing line of business, with GTV growth of 2.6x YoY to Rs. 111.34 Cr in Q2 FY27. The revenue from Hotels grew over 6x to Rs. 8.1 Cr in Q2 FY27. This growth was driven by a significant increase in room nights booked, crossing 4.7 lakhs for the quarter, growing 295% YoY.
As a result, ixigo’s Hotels business is poised to be a major growth engine for the company in the future. The company continues to invest in supply, product, and customer experience, aiming for emerging product-market fit in Hotels.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Le Travenues Technology Limited
Le Travenues Technology Limited belongs to the Consumer Cyclical › Travel Services sector. Here’s a quick read on where the business and the stock stand today.
Le drops 27.7% over three months and trades near its 52-week lows. Thin margins at 6.7% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue grows at 34.8% and profits at 49.4% CAGR. Both numbers are exceptional. The stock sits at 3% of its 52-week range, close to annual lows. Historically, value investors build positions at these levels — though cheap stocks can stay cheap. Revenue grows at 34.8% and profits at 49.4% CAGR, with D/E of 0.06. Meanwhile, the stock dips 27.7% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Le Travenues Technology Limited.
Auto Manufacturers
Hero Motocorp Limited Launches All-new Xtreme 160R 4V and Refreshed Xtreme 250R
Hero MotoCorp Limited (HEROMOTOCO) launches all-new Xtreme 160R 4V and refreshed Xtreme 250R, marking a significant step in its premiumization journey.
Hero MotoCorp Limited (HEROMOTOCO) is accelerating its premium growth ambitions with the launch of the all-new Xtreme 160R 4V and refreshed Xtreme 250R. The twin launch marks a significant step in strengthening the company’s premium motorcycle portfolio, bringing together sharper streetfighter styling, exhilarating performance, and advanced rider-focused technology across two key segments.
All-New Xtreme 160R 4V
Since its debut in 2023, the Xtreme 160R 4V has been a key pillar of Hero MotoCorp’s premium motorcycle portfolio. The all-new model is its most comprehensive transformation yet: a complete redesign carrying the Xtreme family DNA, segment-leading performance, and a host of innovative technology.
Refreshed Xtreme 250R
The refreshed Xtreme 250R raises the bar in the 250cc performance segment with enhanced performance, advanced technology, sharper dynamics, and premium design and finish. Combining track-inspired technology and confidence-inspiring handling with everyday usability, it delivers an exhilarating, well-rounded riding experience.
Hero MotoCorp Limited remains committed to delivering aspirational, technology-led products and accelerating its premiumization journey.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Hero MotoCorp Limited
Hero MotoCorp Limited belongs to the Consumer Cyclical › Auto Manufacturers sector. Here’s a quick read on where the business and the stock stand today.
Hero posts a 6.4% three-month gain, but softens in the last few weeks. The PEG of 0.71 signals undervaluation relative to growth. It is a potential re-rating candidate. D/E stands at 0.00 with a 3.55% dividend yield. Furthermore, the business records zero revenue dips and zero loss quarters in five years — a fortress balance sheet. The stock gives back 0.2% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 11.7% and profits at 26.9%, and the dividend yield stands at 3.55%. The business is in good shape. Moreover, a stock that does not move despite strong fundamentals often offers better value than one already priced for perfection. Check Fundamentals of Hero MotoCorp Limited.
Consumer Cyclical
Indo Rama Synthetics (india) Limited Q2fy27: Profit Growth and Margin Expansion
Indo Rama Synthetics (INDORAMA) reports Q2FY27 results with 10% revenue growth, 201.8% PAT increase, and margin expansion.
Indo Rama Synthetics (India) Limited (INDORAMA) announced its financial results for the quarter ending September 30, 2026, marking a strong quarter of profit growth and margin expansion. The company reported total income of ₹1,344 crore, registering a 10% year-on-year (YoY) growth and a 43% quarter-on-quarter (QoQ) increase.
Revenue Performance
The company’s revenue performance highlights the robust growth despite a challenging operating environment. Consolidated total income stood at ₹1,344 crore in Q2 FY27, compared with ₹1,222.4 crore in Q2 FY26.
Strong EBITDA Growth
EBITDA increased by 46.4% YoY to ₹117.7 crore in Q2 FY27, compared with ₹80.4 crore in Q2 FY26. For H1 FY27, EBITDA grew by 24.9% YoY to ₹225.7 crore.
Robust Profitability Growth
Profit After Tax (PAT) increased to ₹74.1 crore in Q2 FY27, compared with ₹24.6 crore in Q2 FY26, representing a 201.8% YoY increase. H1 FY27 PAT rose by 78.3% YoY to ₹137.8 crore.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Indo Rama Synthetics (India) Limited
Indo Rama Synthetics (India) Limited belongs to the Consumer Cyclical › Textile Manufacturing sector. Here’s a quick read on where the business and the stock stand today.
Indo gains 94.8% over three months and trades near its 52-week highs. Razor-thin margins below 5% make profitability extremely vulnerable — this business needs scale or pricing power urgently. No meaningful dividend — total return is entirely dependent on capital appreciation. Buyers show up with 1.5x the volume of sellers. Moreover, they dominated on 18 of recent sessions versus 12 for sellers — a healthy accumulation pattern. The stock rises 94.8% in three months on 6.1% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of Indo Rama Synthetics (India) Limited.
-
Industrials3 days agoReliance Industrial Infrastructure Limited (riil) Reports Q2 Fy26-27 Results: Income Down, Profit Margins Narrow
-
Financial Services3 days agoIcici Lombard General Insurance Company Limited Q2 Fy2027: Profit Soars by 27.5% Declares Interim Dividend of ₹7.00 Per Share
-
Auto Manufacturers3 days agoHyundai Motor India Limited Celebrates 30 Years with Maharashtra Cm’s Plant Inauguration
-
Auto Parts3 days agoCeat Limited Q2 FY27: Investor Presentation Highlights Road to Siberia Expansion
-
Healthcare2 days agoMankind Pharma Limited to Acquire Majority Stake in Armed Cell Therapeutics, Marking Strategic Entry into Next-generation CAR-T Therapies
-
Consumer Defensive3 days agoNiit Limited (NSE: Niitltd) Appoints Anish Sarkar as Chief Executive Officer
-
BAJAJCON3 days agoBajaj Consumer Care Limited (bajajcon) Q2 FY27: Strong Growth & Margin Momentum
-
ANGELONE2 days agoAngel One Limited (NSE: Angelone) Q2 FY27: Revenue and PAT Surge, Client Funding Book Hits ₹74.5 Bn
